According to Renovaro Biosciences's latest financial reports the company's current earnings (TTM) are -ยฃ41.1 M. In 2023 the company made an earning of -ยฃ31.42 M an increase over its 2022 earnings that were of -ยฃ82.75 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.